Trial intelligence / Profile preview

METRO: Insulin Pump vs MDI in Young Adults with T1DM

NCT03463564Phase 4Recruiting

Sponsor
University of Campania Luigi Vanvitelli
Start
Jan 2016
Primary completion
Dec 2026
Countries
1
01

Overview

Phase 4, open-label trial (2 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoints: Change in Glycated Hemoglobin at 24 months, Change in Mean Amplitude of Glucose Excursions at 24 months and 3 more. Started Jan 2016; status: recruiting.

Beyond the preview

Go deeper on NCT03463564.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03463564.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call